|
|
|
Vol. 14, No. 8, pp. 951-962, April 15, 2000
1 Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, and 2 Department of Oral Biology, Harvard School of Dental Medicine, Boston, Massachusetts 02115 USA
| |
ABSTRACT |
|---|
|
|
|---|
The basal transcription factor TFIID consists of the TATA-binding protein (TBP) and TBP-associated factors (TAFs). Yeast Taf67 is homologous to mammalian TAFII55. Using a yeast two-hybrid screen to identify proteins that interact with Taf67, we isolated Bromodomain factor 1 (Bdf1) and its homolog (Bdf2). The Bdf proteins are genetically redundant, as cells are inviable without at least one of the two BDF genes. Both proteins contain two bromodomains, a motif found in several proteins involved in transcription and chromatin modification. The BDF genes interact genetically with TAF67. Furthermore, Bdf1 associates with TFIID and is recruited to a TATA-containing promoter. Deletion of Bdf1 or the Taf67 Bdf-interacting domain leads to defects in gene expression. Interestingly, the higher eukaryotic TAFII250 has an acetyltransferase activity, two bromodomains, and an associated kinase activity. Its yeast homolog, Taf145, has acetyltransferase activity but lacks the bromodomains and kinase. Bdf1, like TAFII250, has a kinase activity that maps carboxy-terminal to the bromodomains. The structural and functional similarities suggest that Bdf1 corresponds to the carboxy-terminal region of higher eukaryotic TAFII250 and that the interaction between TFIID and Bdf1 is important for proper gene expression.
[Key Words: TFIID; bromodomain; transcription; kinase]
| |
Introduction |
|---|
|
|
|---|
Expression of most genes is controlled at the level of
transcription initiation. Transcription by RNA
polymerase II (Pol II) requires the assembly of multiple basal
transcription factors into a preinitiation complex (PIC) at the core
promoter. Promoter recognition is mediated by TFIID. TFIID consists of
TATA-binding protein (TBP), which is necessary and sufficient for
binding to the TATA element, and 10-12 TBP-associated factors (TAFs).
The yeast TAFs are essential for viability, but their role in
transcription is still not well understood. Several roles for TAFs have
been proposed, including mediation of activated transcription, core promoter selectivity, and cell cycle regulation of transcription (for
review, see Verrijzer and Tjian 1996
). One recent report suggests that
TAFs are required for transcription from chromatin templates (Wu et al.
1999
). In vitro experiments suggested that TAFs interact with upstream
binding factors to activate transcription (Verrijzer and Tjian 1996
).
However, other experiments indicate that activated transcription can
occur in vitro without TAFs (Burley and Roeder 1996
; Oelgeschlager et
al. 1998
; Wu and Chiang 1998
).
Experiments in yeast using temperature-sensitive mutants or targeted
depletion of TAFs showed that some TAFs may not be generally required
for RNA Pol II transcription (Moqtaderi et al. 1996b
; Walker et al.
1996
). Mutations in yeast Taf145 or mammalian TAFII250, the
largest subunit of TFIID, lead to gene-specific defects rather than a
general defect in transcription (Walker et al. 1996
; Wang et al. 1997
).
In contrast, several groups reported a more widespread role for the
histone-like TAFs in transcription (Apone et al. 1998
; Michel et al.
1998
; Moqtaderi et al. 1998
; Natarajan et al. 1998
).
A subset of TAFs, including the histone-like TAFs, also associate with
the SAGA (Spt-Ada-Gcn5
Acetyltransferase) complex in yeast (Grant et al. 1998a
).
The corresponding mammalian TAFs or homologs are found in the
P/CAF and TFTC acetyltransferase complexes (for review,
see Bell and Tora 1999
). Therefore, effects of histone-like TAF
inactivation result from the simultaneous disruption of both TFIID and
SAGA. SAGA-specific components are nonessential (Grant et al. 1998b
).
Also, deletion of SPT20, which causes a complete loss of SAGA
complex (Grant et al. 1997
), does not result in a general decrease in
poly(A) mRNA level (Michel et al. 1998
). Therefore, although it is an
important regulator of transcription, SAGA is not generally required
for gene expression. Specific disruption of the TFIID complex by a
mutation in the TFIID-specific Taf40 protein also causes a widespread
loss of RNA Pol II transcription (Komarnitsky et al. 1999
). Thus,
although every TAF may not be required at all promoters, it is likely
that TFIID is the species that delivers TBP to Pol II promoters in vivo.
Taf67 is the yeast homolog of human TAFII55 (Chiang and
Roeder 1995
; Lavigne et al. 1996
; Moqtaderi et al. 1996a
). Studies of
hTAFII55 suggest that this TAF may be a target of activators (Chiang and Roeder 1995
; Lavigne et al. 1999
). To study the functions of TAFs and TFIID further, a yeast two-hybrid screen was used to
identify proteins that interact with yeast Taf67. Two proteins, Bromodomain factor1 (Bdf1) and its homolog (Bdf2) were isolated.
Bdf1 has been implicated previously in transcription of several genes
including snRNAs (Lygerou et al. 1994
). However, another genetic screen
identified Bdf1 as a chromosomal protein required for sporulation (Chua
and Roeder 1995
). BDF1 is nonessential, but deletion causes
several phenotypes including temperature sensitivity, slow growth,
flocculence in liquid culture, and defects in the utilization of some
carbon sources. Bdf1 has some sequence similarity to human RING3 and
hOrfX proteins, as well as the Drosophila female sterile
homeotic protein (Lygerou et al. 1994
; Chua and Roeder 1995
). Human
RING3 was identified as a mitogen-activated nuclear kinase with
autophosphorylation activity (Denis and Green 1996
). A mouse homolog of
RING3 is associated with a mammalian mediator complex (Jiang et al.
1998
). The similarity between these proteins and Bdf1 is largely
concentrated in two copies of a motif known as the bromodomain. The
function of the bromodomain is still unknown, and its importance varies
in different proteins. However, there is growing evidence that
bromodomains bind to the amino-terminal tails of histones, with a
strong preference for the acetylated forms (for review, see Winston and
Allis 1999
).
Interestingly, the largest higher eukaryotic TAF (TAFII250 or
Ccg1) also contains two bromodomains and an autokinase activity in its
carboxy-terminal half. The amino terminal half of TAFII250 possesses HAT activity (Dikstein et al. 1996
; Mizzen et al. 1996
). Taf145, the yeast homolog of TAFII250, possesses HAT activity but lacks the two bromodomains and kinase activity. Here, we show that
Bdf1 interacts with Taf67 and TFIID genetically and biochemically, and
that this interaction plays a role in the regulation of transcription. Furthermore, Bdf1 is also able to autophosphorylate. The structural and
functional properties of the protein suggest that Bdf1 corresponds to
the carboxy-terminal region of TAFII250.
| |
Results |
|---|
|
|
|---|
Bdf1 and Bdf2 interact with Taf67
To explore the interactions between TFIID subunits, a yeast two-hybrid screen was performed to identify proteins that could interact with a Gal4-binding domain-Taf67 fusion. Using a library containing yeast cDNAs fused to the Gal4 activation domain, plasmids were isolated that scored positive in combination with the Taf67 fusion. Of 250,000 clones screened, two were isolated that reproducibly and specifically interacted with the Taf67 fusion. Sequencing of the two clones revealed that one carried the previously described BDF1 gene. The second was identified as YDL070W. Interestingly, a homology search revealed that the YDL070W protein has significant sequence similarity to Bdf1. Because of their physical and functional similarities (see below), YDL070W has been designated Bdf2. Both proteins contain two bromodomain motifs, believed to encode a protein module involved in binding to histone tails.
Deletion mapping of both Bdf1 and Bdf2 indicated that the bromodomains
were not necessary for interaction with Taf67 (Fig. 1). Rather, the conserved region carboxy-terminal to
the bromodomains was necessary and sufficient for interaction. In the
Bdf1 protein, Taf67 interaction mapped between residues 494 and 626. Interestingly, expression of several of the Gal4 activation domain-Bdf1
truncation constructs lacking this region but containing bromodomains
led to reduced growth rates even in the presence of wild-type Bdf proteins (data not shown). This result echoes the observation of Chua
and Roeder (1995)
that a Bdf1 protein fused to lacZ near the
carboxyl terminus was lethal. Therefore, partially functional Bdf1
fragments may interfere with the function of the wild-type protein. We
also noted that high-copy plasmids containing BDF1 also caused
some growth retardation, suggesting a titration of some important
limiting factor in cells.
|
To determine which region of Taf67 interacts with the Bdf proteins,
different parts of Taf67 were fused to the Gal4 DNA-binding domain and
tested in the two-hybrid system. The amino-terminal 100 amino acids
were necessary and sufficient for interaction. This region is rich in
basic amino acids and is not conserved in the mammalian homolog
TAFII55. Another interesting property of this region was
noted in the context of the Gal4-binding domain fusions. Unlike many
other yeast Tafs that are strong transcriptional activators when fused
to a binding domain (Keaveney and Struhl 1998
), full-length Taf67 did
not activate transcription. However, when the amino-terminal 101 amino
acids were deleted, the remaining portion of Taf67 became a potent
transcriptional activator. Transcription activation function mapped to
residues between 222 and 377, a region conserved over evolution (Fig.
1). In human TAFII55, this region interacts directly with
TAFII250 (Chiang and Roeder 1995
). The differential ability
of the full-length and truncated Taf67 proteins to activate
transcription was also seen in a BDF1 null background (not
shown). It has been argued that activation by Taf and TBP fusions
results from recruitment of the entire TFIID complex to the
Gal4-binding site. We speculate that the Bdf-interacting region might
modulate the interaction between Taf67 and the rest of the TFIID complex.
Bdf1 and Bdf2 are redundant
BDF1 is not essential for viability, but deletion does
cause temperature sensitivity, slow growth, flocculence in liquid
culture, sensitivity to the DNA-damaging agent MMS, poor sporulation,
and inability to grow on nonfermentable carbon sources (Lygerou et al.
1994
; Chua and Roeder 1995
). BDF2 has not been characterized previously, so one copy of the gene was replaced with the HIS3 gene in a diploid strain. Sporulation yielded four viable cells and the
BDF2 deletion spores grew indistinguishably from wild-type cells. No mutant phenotypes were observed at high or low temperatures, on different carbon sources, in the absence of inositol, or in the
presence of caffeine.
Because neither BDF1 nor BDF2 are essential, haploid strains carrying the individual deletions were crossed and sporulated. Of 10 tetrads tested, several had fewer than 4 viable spores and no spores carrying both deletions were recovered. Analysis of the remaining viable spores indicated that the nonviable spores corresponded to double deletions (data not shown). A haploid strain was also constructed containing both deletions and the BDF1 gene on a URA3 plasmid. This strain was unable to grow in the presence of 5-FOA unless transformed with another plasmid carrying either BDF1 or BDF2. Therefore, BDF1 and BDF2 are genetically redundant, with at least one being necessary for viability. Another argument for functional redundancy of the two Bdf proteins was the finding that a high-copy plasmid carrying BDF2 suppresses the temperature sensitivity of a BDF1 deletion strain (data not shown).
The Bdf-interacting domain is important for Taf67 function
An alignment shows that the Taf67 protein contains two regions not
found in its mammalian homolog, a basic region on its amino terminus
and an extremely acidic extension at the carboxyl terminus (Moqtaderi
et al. 1996a
). To determine whether these regions were important for
Taf67 function, a series of deletion constructs was tested for the
ability to complement a complete TAF67 deletion (Fig.
2). It was determined that up to 176 amino acids,
including the acidic extension and part of the conserved region, could
be deleted from the carboxyl terminus without loss of viability.
|
The yeast two-hybrid results showed that the amino-terminal region of
Taf67 interacts with the Bdf proteins. A deletion lacking 221 amino
acids from the amino terminus could not support viability. In contrast,
a Taf67 protein lacking the first 101 amino acids, the minimum region
necessary for Bdf interaction, allowed growth, but with several mutant
phenotypes. taf67
N101 cells grew very slowly,
were temperature sensitive, flocculent in liquid culture, and unable to
grow on galactose as a carbon source. These phenotypes are also seen in
a bdf1
strain, consistent with the hypothesis that the Taf67 amino-terminal region mediates the interaction between
the two proteins.
Because the Bdf-interaction domain of Taf67 appeared to be important
for its function, we tested whether overexpression of Bdf1 or Bdf2
could suppress the temperature sensitivity of a
taf67
N101 strain. No suppression was seen; in
fact, cells overexpressing Bdf proteins grew slower whether they
contained a wild-type or mutant TAF67 allele. Similarly,
overexpression of Taf67 did not suppress the temperature sensitivity of
the BDF1 deletion. However, taf67
N101
was synthetically lethal in combination with either bdf1
or bdf2
(data not
shown), providing further genetic evidence for a functional interaction
between the proteins.
The Bdf-interacting domain of Taf67 is important for proper gene expression
To determine whether the interaction between Taf67 and Bdf1 plays a
role in transcription, temperature-sensitive strains carrying the
taf67
N101 or bdf1
allele were analyzed at nonpermissive temperature. The mutants and
their isogenic wild-type strains were grown at room temperature.
Samples were collected at various times after shifting to 37°C and
RNA was isolated. Nuclease protection was used to determine the levels
of RPS4 and HTA2 transcripts (Fig.
3A) and Northern blotting was performed for
ACT1 mRNA (Fig. 3B). The taf67
N101
strain showed a decrease in all three transcripts after shift to
nonpermissive temperature. The kinetics of reduction were similar to
those seen previously with taf40, taf60, and
taf61 temperature-sensitive strains (Michel et al. 1998
;
Komarnitsky et al. 1999
). However, levels of total poly(A)+ mRNA in
the taf67
N101 strain remained high for at least
6 hr after temperature shift, suggesting that this allele did not
result in a complete loss of transcription (referred to as
taf67-1 in Michel et al. 1998
).
|
In contrast to taf67
N101, the
bdf1
strain did not exhibit a decrease in any
of the three mRNAs at the nonpermissive temperature. Also,
taf67
N101 extracts were inactive for in vitro
transcription, whereas bdf1
extracts had weak
activity (data not shown). The bdf1
strain
still contains wild-type Bdf2, which is likely to be functionally
redundant with Bdf1. Therefore, we cannot conclusively determine
whether Bdf1 and Bdf2 play a widespread role in Pol II transcription
from these experiments. The phenotypes of the BDF1 deletion
could be explained by selective transcription defects.
As TAFs have been postulated to have a coactivator function, we tested
whether Taf67 and Bdf1 play a role in gene activation. The inducible
genes GAL10 and CUP1 were assayed in
taf67
N101, bdf1
, and
the corresponding isogenic wild-type strains. Cells were grown in the
presence of galactose for induction of GAL10 or copper for
induction of CUP1. Northern blot analysis was used to detect
the level of GAL10 and CUP1 messages. Activation of GAL10 is clearly defective in both
taf67
N101 and bdf1
strains (Fig. 3C), consistent with the Gal
phenotype of both
strains. In contrast, activation of CUP1 by copper is normal
in both mutant strains. CUP1 induction is also independent of
several essential transcription factors such as Kin28, Srb4, the CTD of
RNA Pol II largest subunit, and Taf17 (Lee and Lis 1998
; McNeil et
al. 1998
; Moqtaderi et al. 1998
) and may be atypical of most genes.
Interestingly, a larger CUP1 mRNA species is observed in both
taf67
N101 and bdf1
strains (denoted with asterisk in Fig. 3C). A similar mRNA was observed
previously during CUP1 transcription by a CTD-truncated Pol
II, apparently resulting from transcription past the normal poly(A)
site (McNeil et al. 1998
). The CTD of Pol II has been shown to play a
crucial role in linking transcription to RNA processing. Perhaps
related to this coupling, TFIID has been suggested to recruit CPSF
(cleavage and polyadenylation
specificity factor) to the initiation
complex. The human homolog of Taf67, hTAFII55, participates
in the interaction between CPSF and the TAF complex (Dantonel et al.
1997
). Further studies will be required to determine whether Taf67 and
Bdf1 play a role in an interaction with polyadenylation machinery.
To further explore defects in gene expression in
taf67
N101 and bdf1
strains, a
-galactosidase assay was utilized to measure levels of
activation from lacZ reporter constructs under the regulation of a GAL UAS or the FUS1 promoter. Yeast cells
harboring the reporter constructs were induced with galactose
(GAL) or
-factor (FUS1). Wild-type strains
showed increasing expression of lacZ over time after induction
with galactose, but both taf67
N101 and
bdf1
strains showed only very low levels of
lacZ expression (data not shown). Similarly, in yeast strains
expressing lacZ under the regulation of the FUS1
promoter, both parent strains expressed increasing amounts of
lacZ in response to
-factor, whereas both taf67
N101 and bdf1
strains did not show any induction at all (data not shown). Other
reporter constructs also exhibited unusual responses, although in some
cases there appeared to be higher levels of transcription in the mutant
strains than in the wild-type isogenic strain (data not shown). These
results support the physiological significance of the interaction
between Bdf1 and Taf67 observed in the yeast two-hybrid assay. Bdf1 and
the amino terminus of Taf67 appear to be important for the proper
regulation of several genes. Future analysis of genome-wide expression
arrays should show whether there are genes that specifically depend on
Bdf1 or Bdf2.
The carboxy-terminal region of Bdf1 interacts with TFIID
To determine whether Bdf1 interacts with Taf67 in the context of the
TFIID complex, a protein interaction assay was used. Glutathione
S-transferase (GST) was fused to the first 30 amino acids and
the carboxy-terminal 266 amino acids of Bdf1 to produce GST-Bdf1(C)
(Chua and Roeder 1995
). Glutathione agarose beads carrying GST-Bdf1(C)
or GST alone were incubated with whole cell extracts from a yeast
strain carrying epitope-tagged Taf67 (Taf67HA) or an untagged wild-type
strain. Bound proteins were analyzed by SDS-PAGE and immunoblotting
(Fig. 4). GST-Bdf1(C) retains Taf67 as well as
Taf145, Taf61, and Taf60; the GST beads did not. This result supports
the hypothesis that Bdf1 interacts with TFIID via its carboxyl terminus.
|
We used coimmunoprecipitation to test whether endogenous Bdf1 is
associated with TFIID in yeast extracts. Whole cell extract containing
epitope-tagged Taf67HA was immunoprecipitated with
-HA monoclonal
antibody (12CA5) or
-Bdf1 antibody. Pellets were analyzed by
SDS-PAGE and immunoblotting (Fig. 5A).
-HA
antibody coimmunoprecipitates Bdf1 in Taf67HA extract (Fig. 5A, lane
6), but not in untagged wild-type extract (Fig. 5A, lane 5). In the reciprocal reaction,
-Bdf1 antibody immunoprecipitates Taf67HA (Fig. 5A, lane 8). Preimmune serum failed to precipitate either factor.
It was noted that detection of Bdf1 coprecipitated with Taf67HA
required a longer exposure time than in other panels. Also, the amount
of Taf67HA coprecipitated with
-Bdf1 pellets was much lower than
that precipitated with
-HA antibody. These results indicate that
Bdf1 interacts with Taf67, but that the association could be weak or
substoichiometric under these experimental conditions.
|
Whole-cell extracts from a wild-type or bdf1
strain were subjected to immunoprecipitation with
-TBP or
-Bdf1 antibody to determine whether native Bdf1 associates with
TFIID as a complex (Fig. 5B). As shown in lane 5,
-TBP antibody
coprecipitates several TAFs as well as Bdf1. Again, detection of Bdf1
required longer exposure time than other TAFs. Immunoprecipitation with
-Bdf1 antibody also precipitates several TAF subunits (lane 7).
Importantly,
-Bdf1 antibody did not precipitate any TAFs in a
bdf1
extract (lane 8). Addition of the
recombinant GST-Bdf1(C) protein to the bdf1
extract (lane 9) restored the ability to precipitate TFIID subunits
with
-Bdf1 antibody. Interestingly, very little TBP was
coprecipitated with Bdf1. This recalls our earlier observation that
immunoprecipitates done with epitope-tagged Taf67 contained much less
TBP than precipitations of extracts containing other tagged TAFs
(Moqtaderi et al. 1996a
). Therefore, Taf67 and Bdf1 may both be less
tightly associated with TFIID complex containing TBP.
Our results indicate that Bdf1 is at least partly associated with the
TFIID complex in vivo and that Bdf1 satisfies the operational definition of a TAF, that is, association with TBP. Significantly,
-Bdf1 precipitates did not contain detectable levels of the SAGA complex components Gcn5 or Ada3 (data not shown). Therefore, unlike a
subset of TAFs, Bdf1 appears to be specifically associated with TFIID.
Bdf1 is recruited to the promoter with the transcription preinitiation complex
If Bdf1 is associated with TFIID and functions in RNA Pol II
transcription, it might be recruited to the promoter as part of the
transcription preinitiation complex (PIC). To test this hypothesis, we
used an immobilized template assay (Cho and Buratowski 1999
) in which
PICs are assembled on DNA templates coupled to beads. Whole cell
extract was incubated with the beads in the presence of the activator
Gal4-VP16. To determine DNA sequence specificity, three different
templates were used, one with the CYC1 basal promoter region and a
Gal4-binding site, one with a Gal4-binding site but no promoter, and
one without any promoter or Gal4-binding site. All three templates
contained an identical G-less cassette. Proteins bound to the beads
were subjected to SDS-PAGE and immunoblot analysis (Fig.
6). Two basal transcription factors [the large
subunit of TFIIE (Tfa1) and TBP] were used as markers for
promoter-dependent PIC assembly. Both proteins were bound only in the
presence of a functional promoter. Significantly, Bdf1 also associated
only with a promoter-containing template. Similar levels of Bdf1 were
also recruited to the promoter in the absence of a Gal4-binding site
(data not shown), indicating that the activator is not required for
promoter association. Therefore, Bdf1 is associated with a promoter in
a manner similar to TBP and other general transcription factors,
consistent with a role in RNA Pol II transcription.
|
Bdf1 has an associated kinase activity
The domain structure of Bdf1 (two bromodomains followed by an acidic region) is similar to a family of proteins that include Drosophila female sterile homeotic and the mammalian RING3 protein. Furthermore, the largest TFIID subunit from higher eukaryotes (TAFII250) also contains two bromodomains and acidic region. Taf145, the yeast homolog of TAFII250, aligns with only the amino-terminal half of TAFII250 and does not contain the bromodomains found in the carboxy-terminal half of TAFII250. This raises the possibility that within yeast TFIID, Bdf1 and/or Bdf2 corresponds to the missing part of TAFII250.
An autophosphorylating kinase activity has been mapped to the
carboxy-terminal region of TAFII250 (Dikstein et al. 1996
). The human RING3 protein also exhibits autophosphorylation activity (Denis and Green 1996
). To investigate whether Bdf1 has a similar activity,
-Bdf1 immunoprecipitates were incubated in
phosphorylation buffer containing [
-32P]ATP.
Phosphorylated proteins were visualized by gel electrophoresis, blotting to a membrane, and autoradiography.
-Bdf1
immunoprecipitates from a wild-type extract contain two major
phosphorylated proteins (Fig. 7A, lane 3) that are
not seen in a bdf1
extract (lane 5). The slower
migrating protein (open arrow) corresponds to Bdf1, which runs in
SDS-PAGE at 94 kD (Lygerou et al. 1994
). A second phosphorylated
protein was observed at 43 kD and represents a potential substrate for
the Bdf1 kinase activity. Addition of recombinant GST-Bdf1(C) protein
to whole cell extract prior to the immunoprecipitation (Fig. 7A, lanes
4 and 6) resulted in phosphorylation of the fusion protein (closed
arrow), indicating that at least one phosphorylation site lies in the
carboxyl terminus of Bdf1. Furthermore, recombinant GST-Bdf1(C) added
to a bdf1
extract was still phosphorylated and
restored coprecipitation of the 43-kD protein, indicating that kinase
activity and binding to the 43-kD protein are associated with the
carboxy-terminal region of Bdf1. We also found phosphorylation of Bdf2
in immunoprecipitates from yeast extract, although the 43-kD band was
not apparent (O. Matangkasombut, unpubl.).
|
Bdf1 could either have intrinsic kinase activity or be associated with
a kinase found in yeast extracts. Bacterially produced full-length Bdf1
and GST-Bdf1(C) apparently autophosphorylate in vitro in the absence
of any additional eukaryotic factors (Fig. 7B). This result suggests
that Bdf1 possesses intrinsic kinase activity and that this activity is
localized to the carboxyl terminus, as reported previously for
TAFII250 and RING3 (Denis and Green 1996
; Dikstein et al.
1996
). However, autophosphorylation activity appeared weaker than
that observed in yeast extracts, suggesting that other proteins
or modifications may stimulate Bdf1 kinase activity. To completely rule
out the possibility that Bdf1 is phosphorylated by other associated
kinases, it will be necessary to identify Bdf1 mutants without kinase activity.
| |
Discussion |
|---|
|
|
|---|
Using a yeast two-hybrid screen, we discovered that Bdf1 and its
homolog Bdf2 interact with the Taf67 TFIID subunit. Genetic and
biochemical evidence support the physiological relevance of this
interaction. Deletion of BDF1 or a truncation of the Taf67 Bdf-interacting domain (taf67
N101) results in
several phenotypes including temperature sensitivity, flocculence, and
selective defects in transcription. Bdf1 associates with TFIID and is
recruited to a promoter with components of the transcription
preinitiation complex. Thus, Bdf1 behaves like a TAF both in vitro and
in vivo. Its domain structure and functional characteristics suggest
that Bdf1 might correspond to the carboxy-terminal half of higher
eukaryotic TAFII250 (Fig. 8A).
|
As TFIID is a key component of the RNA Pol II transcription machinery,
disruption of the Taf67/Bdf interaction might be expected to affect gene expression. At 30°C, neither a
taf67
N101 nor bdf1
strain induce GAL10 transcription in the presence of galactose or a FUS1 reporter gene in the presence of
-factor. Upon
shifting the temperature-sensitive taf67
N101
strain to the nonpermissive temperature, additional transcription
defects are observed including a loss of ACT1, RPS4,
and HTA2 transcription. However, total poly(A)+ mRNA levels
do not dramatically decrease (Michel et al. 1998
; data not shown).
Recently, the Schizosaccharomyces pombe homolog of Taf67,
ptr6+ [poly(A)+ RNA
transport] was the implicated nucleocytoplasmic
transport of mRNA (Shibuya et al. 1999
). A temperature-sensitive
ptr6 mutant strain shows a widespread defect in Pol II
transcription after shifting to nonpermissive temperature and this may
indirectly contribute to the transport defect. The difference between
the specific gene expression defects seen with our
taf67
N101 strain and the general defect with
the ptr6 mutant could reflect different roles of the Taf in
the two species. We suspect that it is more likely due to differences
in allele severity because the taf67
N101 strain
does not show the rapid cessation of growth and loss of viability that
correlates with loss of transcription in our other Taf mutants (Michel
et al. 1998
; Komarnitsky et al. 1999
).
The bdf1
strain also does not show reduced
levels of poly(A)+ RNA at the nonpermissive temperature.
Furthermore, it has only a subset of the gene expression defects seen
with taf67
N101. This may be because Bdf2 can
function in place of Bdf1. This idea is supported by the findings that
the double deletion of BDF1 and BDF2 is inviable and
that overexpression of BDF2 suppresses the temperature
sensitivity of bdf1
. If either Bdf1 or Bdf2 can function in association with Taf67, there may be two functionally distinct forms of TFIID within yeast cells. It is clear that Bdf1 and
Bdf2 are not completely redundant as bdf1
shows
more severe phenotypes than bdf2
. Therefore,
there may be promoters that function specifically with only Bdf1- or
Bdf2-associated TFIID. Alternatively, Bdf1 could be the major
bromodomain factor, whereas Bdf2 is normally used only under certain
growth conditions.
The Bdf proteins contain two bromodomains and an acidic carboxyl
terminus. It is intriguing that these same features are seen in
TAFII250 from higher eukaryotes, but are missing in its yeast homolog Taf145. The TAFII250 carboxy-terminal region and
RING3 exhibit autophosphorylation activity (Denis and Green 1996
;
Dikstein et al. 1996
) and we observe a similar activity in the
carboxy-terminal region of Bdf1. Neither TAFII250, Bdf1, or
RING3 closely resemble known kinases and may therefore represent a new
kinase family. It will be interesting to determine the functional role
of autophosphorylation, as well as the identities of any heterologous substrates.
Intriguingly, the bromodomain is found almost exclusively in proteins
involved in transcription and chromatin structure such as nuclear
histone acetyltransferases (HATs) and chromatin remodeling factors
(Jeanmougin et al. 1997
). The importance of the bromodomain varies in
different proteins (for review, see Winston and Allis 1999
). The Gcn5
bromodomain specifically stimulates acetylation of nucleosomes relative
to free histones by the SAGA complex (Sterner et al.1999
) and can
interact with histone H3 and H4 amino-terminal tails (Ornaghi et al.
1999
). The P/CAF bromodomain interacts specifically with
an acetyl-lysine analog (Dhalluin et al. 1999
). On the basis of these
findings, it has been proposed that bromodomains function to target
their respective protein complexes to acetylated nucleosomes (Dhalluin
et al. 1999
; Winston and Allis 1999
). Because several HAT complexes
themselves contain bromodomains, this could be an important feedback
mechanism for maintaining the acetylated state of a nucleosome.
How does nucleosome acetylation lead to increased transcription? One
model postulates that promoters within acetylated nucleosomes are
simply more accessible to regulatory and basal transcription factors
because of a less compact chromatin structure. Our results raise the
possibility of a more direct mechanism (Fig. 8B). Transcription activators could recruit one or more HAT complexes to a promoter, resulting in localized nucleosome acetylation (Natarajan et al. 1998
;
Cosma et al. 1999
). Mediated by the two bromodomains of the Bdf
proteins (or TAFII250 in higher eukaryotes), TFIID could be
localized to these acetylated nucleosomes and preferentially delivered
to nearby promoters. This is consistent with the gene expression
defects observed in the Bdf1 and Taf67 mutants. It also explains the
dominant-negative effects seen upon overexpression of full-length or
truncated Bdf1 derivatives (Chua and Roeder 1995
; this work): These
might bind acetylated nucleosomes and block TFIID recruitment.
Several other proteins show a domain arrangement similar to Bdf1 and
Bdf2, including the mammalian RING3 and the Drosophila female
sterile homeotic proteins. One might predict that these proteins serve
to recruit Pol II or other cellular machineries to acetylated
nucleosomes. Consistent with this proposal, a mouse RING3 protein has
been found associated with a mammalian mediator complex (Jiang et al.
1998
). The two-bromodomain-acidic kinase domain arrangement may be a
functional module that has been permanently incorporated into
TAFII250 during evolution of higher eukaryotes. It will be
interesting to see whether similar modules act in transcription by the
RNA Pol I and Pol III systems or in other processes such as replication
and DNA repair.
| |
Materials and methods |
|---|
|
|
|---|
RNA analysis
Yeast cells were grown to early log phase at room temperature and
then shifted to the nonpermissive temperature of 37°C. At the
indicated times, cells were harvested and washed once with cold water.
For GAL10 induction, cells were grown in selective medium
containing 2% raffinose to early log phase and divided in half. The
medium was changed to 2% galactose for induction of GAL10 in
one-half and kept at 2% raffinose in the other half as a negative
control. For CUP1 induction, cells were grown to early log
phase in the absence of copper and divided in half. Copper sulfate
(CuSO4) was added to 1 mM final concentration in the induced culture. Samples were collected after 1 hr of induction for
GAL10 and 30 min for CUP1. RNA was isolated by hot
acid phenol extraction (Ausubel et al. 1991
) and concentration was
determined by measuring the absorbance (A260).
S1 nuclease protection assays were performed as described (Michel et
al. 1998
; Komarnitsky et al. 1999
). Northern blot analysis was
performed as described (Ausubel et al. 1991
). RNA (20 µg/lane) was electrophoresed on 1% agarose
formaldehyde gels and transferred to GeneScreen (DuPont). Transcripts
were detected by hybridizing with radioactively labeled antisense
riboprobes that were generated as described (Fresco and Buratowski 1996
).
Yeast methods
Yeast strains used in this study are listed in Table
1. Reporter constructs used were pLGSD5 containing
the GAL UAS and CYC1 promoter driving lacZ
expression (gift of L. Guarente, MIT, Cambridge, MA), and pSB231
containing the FUS1 promoter driving lacZ expression (gift of
E. Elion, Harvard Medical School, Boston, MA). Cells were grown to
mid-log phase in selective medium and subjected to induction by
galactose for pLGSD5 or
-factor for pSB231. For pLGSD5, the
induction was done by switching the medium to 2% raffinose plus 2%
galactose and the samples were collected at the indicated time points
after induction. For pSB231,
-factor was added to a final
concentration of 5 µM and cells were harvested after 2 hr
of induction.
-galactosidase assays were performed as described (Ausubel et al. 1991
).
|
The effect of deleting both Bdf1 and Bdf2 was tested by crossing YSB496
and YSB485 to generate YSB490, followed by sporulation. Also, the
double deletion strain YSB525 was constructed by sequentially transforming YSB520 with pJA73-BDF2 and the Bdf1 deletion construct pCB74 (Chua and Roeder 1995
). YSB525 was used for complementation testing of Bdf1 deletion derivatives by plasmid shuffling (Fig. 2).
Yeast two-hybrid experiments were carried out as described in Durfee et
al. (1993)
(strain Y153) and Feilotter et al. (1994)
(strain HF7c)
using the GAL-HIS3 reporter. Plasmid constructs encoding Gal4
fusions were made in vectors from Durfee et al. (1993)
and Sadowski et
al. (1994)
. Details of plasmid construction will be provided upon request.
Protein preparation
Yeast whole cell extracts were prepared as in Woontner et al.
(1991)
with minor modifications.
Recombinant GST-Bdf1 and GST-Bdf1(C) were expressed from plasmids
pGEX-1-BDF1 and pCB152, respectively (provided by G.S. Roeder; see Chua
and Roeder 1995
), in Escherichia coli BL21. The GST-Bdf1(C) fusion protein contains the first 30 amino acids and the last 236 amino
acids of Bdf1 fused to glutathione S-transferase. Cells were
grown to OD600 of 0.6 at 37°C, induced with 0.1 mM of IPTG, and further grown at room temperature overnight.
Cells were lysed in PBS with 0.1% Triton X-100 and cleared lysate was
incubated with glutathione agarose beads (Sigma) at 4°C overnight on
a rotator. The beads were washed extensively with the same buffer and
bound proteins were eluted with 50 mM Tris buffer at pH 8.0 containing 5 mM reduced glutathione (Sigma). Eluted fractions
were dialyzed against GST-binding buffer (50 mM HEPES at pH
7.5, 100 mM potassium acetate, 20 mM magnesium
acetate, 5 mM EGTA, 1 µM DTT, 10% glycerol, amd 0.01% NP-40 supplemented with 1 mM PMSF, protease
inhibitors, and 0.03% Triton X-100). Protein concentration was
determined by Bradford assay.
Protein interaction assay
Recombinant GST (provided by E. J. Cho, Harvard Medical School) or GST-Bdf1(C) was immobilized on glutathione agarose beads (100 µg protein/100 µl bed volume). Whole cell extracts (200 µg) were precleared by incubation with 10 µl-bed volume of GST bound agarose beads for 1 hr at 4°C in binding reaction adjusted to 200 µl with GST-binding buffer (described above). Precleared extracts were then incubated with 20 µl-bed volume of GST-Bdf1(C) or GST bound beads at 4°C overnight on a rotator. The beads were washed five times with 200 µl of GST-binding buffer and bound proteins were resolved by SDS-PAGE. Proteins were detected by immunoblotting.
Immunoprecipitations and immunoblotting
Immunoprecipitations were performed as described (Moqtaderi et al.
1996a
) with some modifications. Briefly, whole cell extracts (500 µg) were precleared by incubation for 1 hr at 4°C with 50 µl
of 10% protein A-Sepharose beads in binding reaction adjusted to 500 µl with buffer A. Precleared extracts were then incubated with 50 µl of 10% protein A-Sepharose beads plus 1 µl of rabbit preimmune serum,
-TBP antibody, or
-Bdf1 antibody (generously provided by G.S. Roeder, Yale University, New Haven, CT) overnight at
4°C on a rotator. The beads were washed five times with 800 µl
of buffer A and subjected to SDS-PAGE analysis. Standard immunoblotting techniques were used to detect proteins present in the immunoprecipitates.
Immobilized template assay
Immobilized template assays were done as described in Cho and
Buratowski (1999)
with some modifications. DNA templates for immobilized template assay were generated by PCR with Vent DNA polymerase using a 5'-biotinylated primer Biotin 60 (ACGGTCACAGCTTGTCTGTAAGC), and Reverse primer. PCR products from
pGAL4CG
, p1xGAL4G
, and p(C2AT)19 were
subjected to agarose gel electrophoresis and electroeluted from gel
slices. These templates all contain an identical 400-nucleotide G-less
cassette (Cho and Buratowski 1999
). The pGAL4CG
contains one
Gal4-binding site and the CYC1 basal promoter region, whereas
the p1xGAL4G
contains the Gal4-binding site without the basal
promoter. Purified DNA fragments were incubated with
streptavidin-linked magnetic beads (Dynabeads M280 Streptavidin, Dynal
Inc.) overnight at room temperature in buffer I (2 M sodium
chloride, 10 mM Tris at pH 7.4, 0.01% NP-40). The beads were
washed three times with buffer I and three times with TE buffer. Prior
to use, the beads were incubated with 0.5 mg/ml BSA for 1 hr at room temperature and briefly washed with transcription reaction
buffer (25 mM HEPES-KOH at pH 7.5, 100 mM potassium
acetate, 10 mM magnesium acetate, 5 mM EGTA, 2.5 mM DTT, 10% glycerol). Whole cell extracts (100 µg) were
incubated with 3 µl of beads in 60 µl of transcription reaction
buffer for 1 hr to allow the assembly of transcription complexes in the
presence of 3 µg of p(C2AT)19 as a competitor for nonspecific binding to the G-less cassette. A total of 500 ng of
Gal4-VP16 (provided by E.J. Cho, Harvard Medical School, Boston, MA)
was also included. The beads were washed extensively with transcription
buffer containing 0.003% NP-40. Bound proteins were resolved by
SDS-PAGE and analyzed by immunoblotting.
Phosphorylation assay
Immunoprecipitations were performed as described above. After the
beads had been washed extensively, they were resuspended in 15 µl
of phosphorylation buffer (20 mM HEPES-KOH at pH 7.5, 100 mM potassium acetate, 7.5 mM magnesium acetate, 2 mM DTT, 1 µM ATP, 2% glycerol) and 0.3 µCi
of [
-32P]ATP. Reactions were incubated at room
temperature for 1 hr on a rotator and then resolved by SDS-PAGE.
Phosphorylated proteins were visualized by autoradiography or PhosphorImager.
| |
Acknowledgments |
|---|
We thank P. Chua and G.S. Roeder for providing Bdf1 strains, plasmids, and antibodies. We also thank E. Elion, S. Elledge, W. Forrester, L. Guarente, I. Sadowski, F. Winston, R. Young for providing plasmids; and J. Reese, M. Green, and T. Weil for TAF antibodies. We thank E. J. Cho for her scientific and technical help. This work was supported by NIH grant GM46498. S.B. is Leukemia and Lymphoma Society Scholar. O.M. is supported by the Anandamahidol Foundation under the Royal Patronage of His Majesty the King of Thailand.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Footnotes |
|---|
Received January 4, 2000; revised version accepted February 25, 2000.
3 Corresponding author.
E-MAIL steveb{at}hms.harvard.edu; FAX (617) 738-0516.
| |
References |
|---|
|
|
|---|